Shuttle Pharmaceuticals Holdings, Inc. – NASDAQ:SHPH

Shuttle Pharmaceuticals Holdings stock price today

$3.17
+2.42
+327.8%
Financial Health
0
1
2
3
4
5
6
7
8
9

Shuttle Pharmaceuticals Holdings stock price monthly change

+74.64%
month

Shuttle Pharmaceuticals Holdings stock price quarterly change

+74.64%
quarter

Shuttle Pharmaceuticals Holdings stock price yearly change

+52.41%
year

Shuttle Pharmaceuticals Holdings key metrics

Market Cap
2.25M
Enterprise value
6.09M
P/E
-4.43
EV/Sales
N/A
EV/EBITDA
-1.59
Price/Sales
N/A
Price/Book
1.79
PEG ratio
0.01
EPS
-0.45
Revenue
N/A
EBITDA
-5.68M
Income
-7.34M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Shuttle Pharmaceuticals Holdings stock price history

Shuttle Pharmaceuticals Holdings stock forecast

Shuttle Pharmaceuticals Holdings financial statements

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH): Profit margin
Jun 2023 0 -2.18M
Sep 2023 0 -1.79M
Dec 2023 9.65K -1.64M -16989.44%
Mar 2024 0 -1.73M
0%
Yield TTM
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH): Payout ratio
Payout ratio 0%
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH): Dividend Yield
2018
2020
2021
2022 0.25%
2023
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH): Debt to assets
Jun 2023 8837101 1.90M 21.52%
Sep 2023 7375818 1.76M 23.94%
Dec 2023 5951736 1.89M 31.86%
Mar 2024 4753921 1.99M 41.91%
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH): Cash Flow
Jun 2023 -1.64M 62.80K -139.22K
Sep 2023 -1.53M -25.85K 0
Dec 2023 -1.06M 87.03K -334.44K
Mar 2024 -1.23M 101.29K -40K

Shuttle Pharmaceuticals Holdings alternative data

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH): Employee count
Aug 2023 7
Sep 2023 7
Oct 2023 7
Nov 2023 7
Dec 2023 7
Jan 2024 7
Feb 2024 7
Mar 2024 8
Apr 2024 8
May 2024 8
Jun 2024 8
Jul 2024 8

Shuttle Pharmaceuticals Holdings other data

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH): Insider trades (number of shares)
Period Buy Sel
Dec 2023 0 7078
Transaction Date Insider Security Shares Price per share Total value Source
Sale
BROWN MILTON director
Common Stock 2,921 $0.46 $1,352
Sale
JACOBS BETTE director
Common Stock 4,157 $0.46 $1,925
Sale
RICHARDS STEVEN M director
COMMON STOCK 995 $1.61 $1,597
Sale
BROWN MILTON director
COMMON STOCK 995 $1.61 $1,597
Sale
ADKINS WILLIAM other: Former Director
COMMON STOCK 995 $1.61 $1,597
Sale
DRITSCHILO ANATOLY director, 10 percent owner, off..
COMMON STOCK 8,372 $1.61 $13,437
Sale
JACOBS BETTE director
CLASS A COMMON STOCK 4,366 $1.61 $7,007
Sale
JUNG MIRA officer: Chief Scientific Officer
CLASS A COMMON STOCK 328 $1.61 $526
Sale
RICH TYVIN officer: Chief Medical Officer
COMMON STOCK 1,414 $1.61 $2,269
Sale
DRITSCHILO PETER officer: President and COO
COMMON STOCK 3,820 $1.61 $6,131
Tuesday, 26 November 2024
globenewswire.com
Wednesday, 13 November 2024
globenewswire.com
Tuesday, 29 October 2024
globenewswire.com
Monday, 28 October 2024
globenewswire.com
Monday, 16 September 2024
globenewswire.com
Wednesday, 4 September 2024
globenewswire.com
Monday, 26 August 2024
globenewswire.com
Wednesday, 14 August 2024
globenewswire.com
Friday, 19 July 2024
globenewswire.com
Tuesday, 18 June 2024
globenewswire.com
Wednesday, 22 May 2024
globenewswire.com
Tuesday, 14 May 2024
globenewswire.com
Tuesday, 23 April 2024
GlobeNewsWire
Wednesday, 3 April 2024
GlobeNewsWire
Wednesday, 24 May 2023
PennyStocks
Friday, 13 January 2023
PennyStocks
Tuesday, 6 December 2022
PennyStocks
Monday, 17 October 2022
24/7 Wall Street
Friday, 16 September 2022
Green Stock News
Friday, 9 September 2022
The Motley Fool
  • What's the price of Shuttle Pharmaceuticals Holdings stock today?

    One share of Shuttle Pharmaceuticals Holdings stock can currently be purchased for approximately $3.17.

  • When is Shuttle Pharmaceuticals Holdings's next earnings date?

    Unfortunately, Shuttle Pharmaceuticals Holdings's (SHPH) next earnings date is currently unknown.

  • Does Shuttle Pharmaceuticals Holdings pay dividends?

    No, Shuttle Pharmaceuticals Holdings does not pay dividends.

  • How much money does Shuttle Pharmaceuticals Holdings make?

    Shuttle Pharmaceuticals Holdings has a market capitalization of 2.25M.

  • What is Shuttle Pharmaceuticals Holdings's stock symbol?

    Shuttle Pharmaceuticals Holdings, Inc. is traded on the NASDAQ under the ticker symbol "SHPH".

  • What is Shuttle Pharmaceuticals Holdings's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Shuttle Pharmaceuticals Holdings?

    Shares of Shuttle Pharmaceuticals Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Shuttle Pharmaceuticals Holdings have?

    As Jul 2024, Shuttle Pharmaceuticals Holdings employs 8 workers.

  • When Shuttle Pharmaceuticals Holdings went public?

    Shuttle Pharmaceuticals Holdings, Inc. is publicly traded company for more then 3 years since IPO on 31 Aug 2022.

  • What is Shuttle Pharmaceuticals Holdings's official website?

    The official website for Shuttle Pharmaceuticals Holdings is shuttlepharma.com.

  • Where are Shuttle Pharmaceuticals Holdings's headquarters?

    Shuttle Pharmaceuticals Holdings is headquartered at One Research Court, Rockville, MD.

  • How can i contact Shuttle Pharmaceuticals Holdings?

    Shuttle Pharmaceuticals Holdings's mailing address is One Research Court, Rockville, MD and company can be reached via phone at +240 4034212.

Shuttle Pharmaceuticals Holdings company profile:

Shuttle Pharmaceuticals Holdings, Inc.

shuttlepharma.com
Exchange:

NASDAQ

Full time employees:

8

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.

One Research Court
Rockville, MD 20850

CIK: 0001757499
ISIN: US8256932034
CUSIP: 825693203